Neil Gibson
Director/Board Member at INSTIL BIO, INC.
Net worth: 515 846 $ as of 2024-04-29
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Taylor Schreiber | M | 44 | 8 years | |
Stephen Stout | M | 49 | 3 years | |
Derek S. Gilchrist | M | - |
Causeway Therapeutics Ltd.
Causeway Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Causeway Therapeutics Ltd. operates as a biotechnology company. It develops drugs for the treatment for patients. The company was founded by Derek S. Gilchrist and Neal L. Millar and is headquartered in Glasgow, the United States. | - |
Nadim Ahmed | M | 56 |
Cullinan Mica Corp.
Cullinan Mica Corp. Pharmaceuticals: MajorHealth Technology Part of Cullinan Therapeutics, Inc., Cullinan Mica Corp. is a company that provides worldwide rights to CLN-619. The company is based in Cambridge, MA. The CEO of the company is Nadim Ahmed. | - |
Sandeep Laumas | M | 56 | 4 years | |
George Golumbeski | M | 67 | 6 years | |
Conor Richardson | M | - | 5 years | |
Bronson Crouch | M | 51 | 6 years | |
William Rastetter | M | 75 | 11 years | |
Carrie Brownstein | M | 54 | 3 years | |
Helen Boudreau | F | 58 | 4 years | |
George Fromm | M | 45 | 7 years | |
Sally Susman | F | 62 | 17 years | |
Christian Vasquez | M | 48 | 9 years | |
George Matcham | M | 72 | 6 years | |
Gwendolyn Binder-Scholl | M | 49 | 4 years | |
Tyler Brous | M | 41 | 8 years | |
Andrew Neill | M | 38 | 5 years | |
Daniel Penksa | M | 39 | 9 years | |
Robert Hawkins | M | 69 | 4 years | |
Neal L. Millar | M | - |
Causeway Therapeutics Ltd.
Causeway Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Causeway Therapeutics Ltd. operates as a biotechnology company. It develops drugs for the treatment for patients. The company was founded by Derek S. Gilchrist and Neal L. Millar and is headquartered in Glasgow, the United States. | - |
Christopher Aker | M | 63 | 13 years | |
Michael Lee | M | 45 | 4 years | |
Peter Olagunju | M | - | 3 years | |
Declan Doogan | M | 72 |
Causeway Therapeutics Ltd.
Causeway Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Causeway Therapeutics Ltd. operates as a biotechnology company. It develops drugs for the treatment for patients. The company was founded by Derek S. Gilchrist and Neal L. Millar and is headquartered in Glasgow, the United States. | 26 years |
Richard McGaughy | M | 52 | 4 years | |
Suzanne Johnson | F | 66 | 17 years | |
Jay Lichter | M | 62 |
Silarus Therapeutics, Inc.
Silarus Therapeutics, Inc. BiotechnologyHealth Technology Silarus Therapeutics, Inc. develops therapeutics targeting erythroferrone for the treatment of iron deficiency and iron overload disorders. The company was founded by Tomas Ganz, Sanford J. Madigan, and Elizabeta Nemeth in May 19, 2014 and is headquartered in La Jolla, CA.
Cullinan Mica Corp.
Cullinan Mica Corp. Pharmaceuticals: MajorHealth Technology Part of Cullinan Therapeutics, Inc., Cullinan Mica Corp. is a company that provides worldwide rights to CLN-619. The company is based in Cambridge, MA. The CEO of the company is Nadim Ahmed. | - |
Lawrence Steinman | M | 76 | 8 years | |
William Bertrand | M | 59 | 1 years | |
Richard Roomberg | M | - | 5 years | |
Suresh de Silva | M | 45 | 6 years | |
Kevin Zikaras | M | - | 6 years | |
Annaliesa Anderson | M | - | 17 years | |
Gregor Cardow | M | - |
Causeway Therapeutics Ltd.
Causeway Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Causeway Therapeutics Ltd. operates as a biotechnology company. It develops drugs for the treatment for patients. The company was founded by Derek S. Gilchrist and Neal L. Millar and is headquartered in Glasgow, the United States. | - |
Lini Pandite | M | 65 | 7 years | |
John Moore | M | 59 | 4 years | |
Viera Muzithras | M | - | 4 years | |
Gregg McConnell | M | - | 4 years | |
Denis Patrick | M | - | 14 years | |
Amy Franke | F | - | 2 years | |
Angela Justice | M | 51 | 5 years | |
Suzanne Boyd | F | - | 3 years | |
Abhinav Shukla | M | 51 | 3 years | |
Thomas M. Lampkin | M | - | 6 years | |
Mikael Dolsten | M | 65 | 15 years | |
Douglas J. Downs | M | - |
Silarus Therapeutics, Inc.
Silarus Therapeutics, Inc. BiotechnologyHealth Technology Silarus Therapeutics, Inc. develops therapeutics targeting erythroferrone for the treatment of iron deficiency and iron overload disorders. The company was founded by Tomas Ganz, Sanford J. Madigan, and Elizabeta Nemeth in May 19, 2014 and is headquartered in La Jolla, CA. | - |
Casi de Young | F | 53 | 5 years | |
Christopher Jones | M | - |
Causeway Therapeutics Ltd.
Causeway Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Causeway Therapeutics Ltd. operates as a biotechnology company. It develops drugs for the treatment for patients. The company was founded by Derek S. Gilchrist and Neal L. Millar and is headquartered in Glasgow, the United States. | 7 years |
Barbara Dalton | M | 69 | 17 years | |
Anthony Adam Rosenberg | M | 71 |
Cullinan Mica Corp.
Cullinan Mica Corp. Pharmaceuticals: MajorHealth Technology Part of Cullinan Therapeutics, Inc., Cullinan Mica Corp. is a company that provides worldwide rights to CLN-619. The company is based in Cambridge, MA. The CEO of the company is Nadim Ahmed. | - |
Mark Dudley | M | - | 3 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Jeffrey Kindler | M | 68 | 8 years | |
Kleanthis Xanthopoulos | M | 66 | 8 years | |
Josiah Hornblower | M | 48 | 5 years | |
Henry McKinnell | M | 81 | 8 years | |
Garry Menzel | M | 59 | 13 years | |
Paul Grint | M | 66 | 3 years | |
David Szekeres | M | 50 | 1 years | |
Daniel Chevallard | M | 44 | 7 years | |
David Shedlarz | M | 75 | 31 years | |
Ansbert Gadicke | M | 66 | 8 years | |
Stephen Webster | M | 63 | 3 years | |
Michael Atieh | M | 70 | 5 years | |
Sumita Ray | F | 50 | 1 years | |
Amy Schulman | F | 63 | 6 years | |
Erin Ator Thomson | F | 44 | - | |
Patrick Baeuerle | M | 66 | 6 years | |
Yuk Fu Chen | M | 75 |
University of Aston
| 7 years |
Paul Fitzhenry | M | 63 | 4 years | |
Bernd Metzner | M | 53 | 4 years | |
Ranjeev Krishana | M | 50 | 7 years | |
Axel Hoos | M | 54 | 3 years | |
David Roblin | M | 57 | 6 years | |
Shawn Tomasello | F | 65 | 2 years | |
John G. Flanagan | M | 65 |
University of Aston
| 8 years |
Dominic Piscitelli | M | 50 | 10 years | |
Victor Stone | M | - | - | |
Fatima Rangwala | M | 49 | 5 years | |
Robert Landry | M | 60 | 4 years | |
Mitchell Finer | M | 65 | 5 years | |
Martin MacKay | M | 68 | 14 years | |
Dana George Mead | M | 88 | 12 years | |
Alan Levin | M | 62 | 20 years | |
Mark Foletta | M | 63 | 5 years | |
Andrew Allen | M | 57 | 5 years | |
Freda Lewis-Hall | M | 69 | 11 years | |
Frances Fergusson | M | 79 | 9 years | |
James Kilts | M | 76 | 13 years | |
Stephen W. Sanger | M | 78 | 9 years | |
Bruce Carter | M | 80 | 3 years | |
Jack Nielsen | M | 60 | 4 years | |
John Maraganore | M | 60 | 7 years | |
Frank D'Amelio | M | 66 | 14 years | |
Barbara Wood | F | 62 | 9 years | |
Morana Jovan-Embiricos | M | 57 | 4 years | |
John Mascotte | M | 84 | 4 years | |
Karl-Ludwig Kley | M | 72 | 16 years | |
Mace Rothenberg | M | 67 | 13 years | |
Alexandra Kropotova | M | 51 | 5 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 92 | 92.00% |
United Kingdom | 7 | 7.00% |
Germany | 3 | 3.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Neil Gibson
- Personal Network